Cargando…

Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies

Zika virus (ZIKV) is a flavivirus that is structurally highly similar to the related viruses, dengue virus (DENV), West Nile virus, and yellow fever virus. ZIKV causes an acute infection that often results in mild symptoms but that can cause severe disease in rare instances. Following infection, ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallichotte, Emily N., Young, Ellen F., Baric, Thomas J., Yount, Boyd L., Metz, Stefan W., Begley, Matthew C., de Silva, Aravinda M., Baric, Ralph S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Observation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751055/ https://www.ncbi.nlm.nih.gov/pubmed/31530669 http://dx.doi.org/10.1128/mBio.01485-19

Ejemplares similares

In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers
por: Metz, Stefan W., et al.
Publicado: (2017)

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes
por: Gallichotte, Emily N., et al.
Publicado: (2018)

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization
por: Gallichotte, Emily N., et al.
Publicado: (2018)

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
por: Collins, Matthew H., et al.
Publicado: (2017)

Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
por: Widman, Douglas G., et al.
Publicado: (2017)

A Reverse Genetics Platform That Spans the Zika Virus Family Tree
por: Widman, Douglas G., et al.
Publicado: (2017)

Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees
por: Martinez, David R., et al.
Publicado: (2020)

Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone
por: Gallichotte, Emily N., et al.
Publicado: (2017)

A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies
por: Graham, Stephen D., et al.
Publicado: (2021)

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus
por: Swanstrom, J. A., et al.
Publicado: (2016)

Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines
por: Swanstrom, Jesica A, et al.
Publicado: (2019)

Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
por: Zhu, Deanna R., et al.
Publicado: (2023)

Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity
por: Dinnon III, Kenneth H., et al.
Publicado: (2019)

Development and Characterization of a Reverse Genetic System for Studying Dengue Virus Serotype 3 Strain Variation and Neutralization
por: Messer, William B., et al.
Publicado: (2012)

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice
por: Chen, Mei-Yu, et al.
Publicado: (2020)

Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
por: Wu, Yanling, et al.
Publicado: (2017)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
por: Boutin, Marianne, et al.
Publicado: (2022)

A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
por: Gallichotte, E. N., et al.
Publicado: (2015)

Neutralization mechanism of a highly potent antibody against Zika virus
por: Zhang, Shuijun, et al.
Publicado: (2016)

Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
por: Wahala, Wahala M. P. B., et al.
Publicado: (2010)

Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication
por: Adams, Lily E., et al.
Publicado: (2021)

Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas
por: Andrade, Daniela V., et al.
Publicado: (2019)

Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
por: White, Laura J., et al.
Publicado: (2021)

Vaccination with a Zika virus envelope domain III protein induces neutralizing antibodies and partial protection against Asian genotype in immunocompetent mice
por: Shin, Minna, et al.
Publicado: (2022)

Efficient Reverse Genetic Systems for Rapid Genetic Manipulation of Emergent and Preemergent Infectious Coronaviruses
por: Cockrell, Adam S., et al.
Publicado: (2017)

Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
por: Tripathi, Lav, et al.
Publicado: (2015)

A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity
por: Young, Ellen, et al.
Publicado: (2023)

Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and Splenocyte Proliferation
por: Cibulski, Samuel, et al.
Publicado: (2021)

Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice
por: Yang, Ming, et al.
Publicado: (2017)

Use of Envelope Domain III Protein for the Detection of IgG Type Antibodies Specific to Zika Virus by Indirect ELISA
por: Ndiaye, Oumar, et al.
Publicado: (2023)

Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier
por: Lorin, Valérie, et al.
Publicado: (2020)

Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
por: Park, Jisang, et al.
Publicado: (2020)

Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure
por: Yang, Chunpeng, et al.
Publicado: (2019)

The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies
por: Kikawa, Caroline, et al.
Publicado: (2023)

The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies
por: Kikawa, Caroline, et al.
Publicado: (2023)

Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71
por: Zhu, Ling, et al.
Publicado: (2018)

Zika Virus Envelope Protein Domain III Produced in K. phaffii Has the Potential for Diagnostic Applications
por: Prates, John Willians Oliveira, et al.
Publicado: (2022)

Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
por: Hoffmann, Markus, et al.
Publicado: (2022)

A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels
por: Markmann, Alena J., et al.
Publicado: (2023)

Renilla Luciferase as a Reporter to Assess SARS-CoV mRNA Transcription Regulation and Efficacy of ANTI-SARS-CoV Agents
por: Roberts, Rhonda S., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_nsqcl11o46vcev8uqpofcl44tf